Iberdomide
Aug 20, 2026 - 00:15:37
Radio and PodcastLive Radio & PodcastsScience & Medicine
Gedatolisib et al
This week's pod covers some brief updates comparing the timelines of the FDA approvals for daraxonrasib vs. enfortuamb vedodin + pembrolizumab, before devoting the rest of the time to the new approval of gedatolisib, a P...
About This Episode
Gedatolisib et al is an episode from OncoPharm by OncoPharmPod. This week's pod covers some brief updates comparing the timelines of the FDA approvals for daraxonrasib vs. enfortuamb vedodin + pembrolizumab, before devoting the rest of the...
Podcast
This episode belongs to OncoPharm.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 23, 2026, 00:18:16 long, audio available.
Related Episodes
Continue listening to more episodes from OncoPharm.
Kidney Cancer in a Nutshell
Aug 13, 2026 - 00:16:12
Small Cell Lung Cancer and CINV Updates
Aug 6, 2026 - 00:17:35
Zidesamtinib & PPIs in Pacific
Jul 30, 2026 - 00:16:32
Endurance Part 2
Jul 16, 2026 - 00:15:12
A Decade of CAR-T, Ocra-T, & POLARGO
Jul 9, 2026 - 00:19:18
Breast Cancer Updates and T-Cell Stemness
Jun 25, 2026 - 00:19:23
Updates on capivasertib, belzutifan, talquetamab, & durvalumab
Jun 18, 2026 - 00:19:32